ZNF695 and breast carcinoma: Its involvement in the stem cell phenotype was particularly evident in breast cancers, in which ZNF695 expression was the most abundant in basal‐like tumors, known for their high content of stem cells (Honeth et al., 2008; Park et al., 2010).